Welcome to the 2021 IGCS Meeting Program Scheduling

The meeting will officially run on Central European Time (Rome time-zone, GMT+2)

To convert the meeting times to your local time Click Here




Displaying One Session

Industry Hall 1

Session Type
Industry Symposia
Industry Hall 1
Session Description
New Perspectives in Ovarian Cancer: Current Paradigm and Long-term Benefits of PARPi Therapy-Supported by Clinical Care Options, LLC

Session description:

The advent of PARP inhibitors continues to change the treatment paradigm for ovarian cancer with emerging data, guideline updates, new approvals, and expanded indications occurring frequently and expected to continue into the future. Unfortunately, many healthcare professionals do not understand the changing landscape of ovarian cancer therapy, specifically their lack of confidence and experience using PARP inhibitors. This educational symposium aims to update HCPs on the latest clinical trial data, long-term benefits of treatment outcomes and the differences in safety and efficacy profiles of the approved PARP inhibitors.

New Perspectives in Ovarian Cancer: Current Paradigm and Long-term Benefits of PARPi Therapy (ID 1069)

Lecture Time
06:50 PM - 06:50 PM

Supported by Clinical Care Options, LLC (ID 1070)

Lecture Time
06:50 PM - 06:50 PM

Welcome and Introduction (ID 1071)

Lecture Time
06:50 PM - 06:55 PM

Advances in ovarian cancer: evolving landscape for PARP inhibitors (ID 1072)

Lecture Time
06:55 PM - 07:05 PM

Biomarkers in ovarian cancer; BRCA and beyond? (ID 1073)

Lecture Time
07:05 PM - 07:15 PM

Clinical application of PARP inhibitors based on clinical cases (ID 1074)

Lecture Time
07:15 PM - 07:35 PM

Summary, Final thoughts, and Audience Q&A (ID 1076)

Lecture Time
07:35 PM - 07:50 PM